Genflow Biosciences (LON:GENF) Stock Falls 0.7% – Here’s Why

Genflow Biosciences plc (LON:GENF – Get Free Report)’s stock price dropped 0.7% during trading on Tuesday. The company traded as low as GBX 1.61 and last traded at GBX 1.64. 214,823 shares were traded during trading, a decline of 90% from the average session volume of 2,128,509 shares. The stock had previously closed at GBX 1.65.

Genflow Biosciences Stock Down 0.7%

The company has a market cap of £9.74 million, a P/E ratio of -7.45 and a beta of 2.29. The firm’s 50 day moving average is GBX 1.88 and its two-hundred day moving average is GBX 2.02.

Genflow Biosciences (LON:GENF – Get Free Report) last issued its quarterly earnings data on Tuesday, September 29th. The company reported GBX (0.08) earnings per share (EPS) for the quarter. Genflow Biosciences had a positive return on equity of 609.63% and a negative net margin of 187.87%.

Genflow Biosciences Company Profile

(Get Free Report)

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.

Further Reading

Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.